logo

NAGE

NiagenยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About NAGE

Niagen Bioscience, Inc.

A dietary supplement and food ingredient company

Pharmaceutical
--
04/25/2016
NASDAQ Stock Exchange
104
12-31
Common stock
10900 Wilshire Blvd. Suite 600, Los Angeles, CA 90024
--
Niagen Bioscience, Inc., is incorporated in Delaware. Niagen is a global bioscience company dedicated to healthy aging. The company's team, including world-renowned scientists, is pioneering research into nicotinamide adenine dinucleotide (NAD +), an essential coenzyme that is a key regulator of cell metabolism and is found in every cell in the body.

Company Financials

EPS

NAGE has released its 2025 Q3 earnings. EPS was reported at 0.05, versus the expected 0.01, beating expectations. The chart below visualizes how NAGE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NAGE has released its 2025 Q3 earnings report, with revenue of 33.99M, reflecting a YoY change of 32.86%, and net profit of 4.58M, showing a YoY change of 143.77%. The Sankey diagram below clearly presents NAGE's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime